5021 - 5030 of 8808 Results
Title
Year
-
OPENTitle: Long-Term Deutetrabenazine Treatment for Tardive Dyskinesia Is Associated With Sustained Benefits and Safety: A 3-Year, Open-Label Extension StudyJournal Name: Frontiers in NeurologyPublisher: Frontiers Media SAVol: 13Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fneur.2022.773999Best OA location URL: https://www.frontiersin.org/articles/10.3389/fneur.2022.773999/pdfCitation Count: 10
- Motor- and cognition-related safety of pimavanserin in patients with Parkinson's disease psychosis2022OPENTitle: Motor- and cognition-related safety of pimavanserin in patients with Parkinson's disease psychosisJournal Name: Frontiers in NeurologyPublisher: Frontiers Media SAVol: 13Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fneur.2022.919778Best OA location URL: https://www.frontiersin.org/articles/10.3389/fneur.2022.919778/pdfCitation Count: 9
-
OPENTitle: DORIS: A diffusion MRI-based 10 tissue class deep learning segmentation algorithm tailored to improve anatomically-constrained tractographyJournal Name: Frontiers in NeuroimagingPublisher: Frontiers Media SAVol: 1Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fnimg.2022.917806Best OA location URL: https://doi.org/10.3389/fnimg.2022.917806Citation Count: 10
-
OPENTitle: OnabotulinumtoxinA Dosing, Disease Severity, and Treatment Benefit in Patients With Cervical Dystonia: A Cohort Analysis From CD PROBEJournal Name: Frontiers in NeurologyPublisher: Frontiers Media SAVol: 13Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fneur.2022.914486Best OA location URL: https://doi.org/10.3389/fneur.2022.914486Citation Count: 7
-
OPENTitle: Clinically important change on the Unified Dyskinesia Rating Scale among patients with Parkinson's disease experiencing dyskinesiaJournal Name: Frontiers in NeurologyPublisher: Frontiers Media SAVol: 13Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fneur.2022.846126Best OA location URL: https://doi.org/10.3389/fneur.2022.846126Citation Count: 5
-
OPENTitle: Characterization of Early Stage Parkinson's Disease From Resting-State fMRI Data Using a Long Short-Term Memory NetworkJournal Name: Frontiers in NeuroimagingPublisher: Frontiers Media SAVol: 1Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fnimg.2022.952084Best OA location URL: https://www.frontiersin.org/articles/10.3389/fnimg.2022.952084/pdfCitation Count: 20
-
OPENTitle: Invariable Ribosome Stoichiometry During Murine Erythroid Differentiation: Implications for Understanding RibosomopathiesJournal Name: Frontiers in Molecular BiosciencesPublisher: Frontiers Media SAVol: 9Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fmolb.2022.805541Best OA location URL: https://doi.org/10.3389/fmolb.2022.805541Citation Count: 4
- Progranulin loss results in sex-dependent dysregulation of the peripheral and central immune system2022OPENTitle: Progranulin loss results in sex-dependent dysregulation of the peripheral and central immune systemJournal Name: Frontiers in ImmunologyPublisher: Frontiers Media SAVol: 13Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fimmu.2022.1056417Best OA location URL: https://doi.org/10.3389/fimmu.2022.1056417Citation Count: 23
-
OPENTitle: The safety/tolerability of opicapone when used early in Parkinson's disease patients with levodopa-induced motor fluctuations: A post-hoc analysis of BIPARK-I and IIJournal Name: Frontiers in NeurologyPublisher: Frontiers Media SAVol: 13Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fneur.2022.994114Best OA location URL: https://doi.org/10.3389/fneur.2022.994114Citation Count: 4
-
OPENTitle: Editorial: Digital Innovation and Data-Driven Research in Neurodegenerative DiseasesJournal Name: Frontiers in NeurologyPublisher: Frontiers Media SAVol: 13Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fneur.2022.961847Best OA location URL: https://www.frontiersin.org/articles/10.3389/fneur.2022.961847/pdfCitation Count: 0